Tag: Her2Overexpressing
Articles
News
Foods
Studies
- 3,3' -diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells
- A Low Carbohydrate, High Protein Diet Slows Tumor Growth and Prevents Cancer Initiation
- A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative
- A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone
- Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer
- Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients
- Additive effects of trastuzumab and genistein on human breast cancer cells
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer
- Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
- Alcohol Promotes Mammary Tumor Development via the Estrogen Pathway in Estrogen Receptor Alpha-Negative HER2/neu Mice
- Anticancer Activities of an Anthocyanin-Rich Extract From Black Rice Against Breast Cancer Cells In Vitro and In Vivo
- Apigenin Induces Apoptosis through Proteasomal Degradation of HER2/neu in HER2/neu-overexpressing Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt-dependent Pathway
- Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry
- Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells
- Biologic markers determine both the risk and the timing of recurrence in breast cancer
- Black Race Is Associated with a Worse Outcome in Patients with Hormone Receptor Positive, HER2-Normal Breast Cancer Treated with Adjuvant Chemohormonal Therapy
- Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression
- Blood Type, Hormone Receptor Status, HER2/neu Status, and Survival in Breast Cancer: A Retrospective Study Exploring Relationships in a Phenotypically Well-Defined Cohort
- Brain metastases free survival differs between breast cancer subtypes
- Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
- Breast cancer in the very elderly: Staging, treatment, and outcomes in patients over age 80
- Breast cancer in very young women
- Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004
- Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies
- Clinically Used Breast Cancer Markers Are Heterogeneous Throughout Tumour Progression
- Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer
- Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer
- Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy
- Conservative surgery in patients with multifocal/multicentric breast cancer
- Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesis
- Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3
- Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo
- Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells
- CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract
- Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu - overexpressing breast cancer cells
- Diabetes mellitus accelerates ErbB2-induced breast carcinogenesis and shortens the survival of a mouse model of breast cancer and diabetes
- Diets High in Corn Oil or Extra-Virgin Olive Oil Provided From Weaning Advance Sexual Maturation and Differentially Modify Susceptibility to Mammary Carcinogenesis in Female Rats
- Differential Influence of Dietary Soy Intake on the Risk of Breast Cancer Recurrence Related to HER2 Status
- Differential response from neoadjuvant chemotherapy across breast cancer subtypes
- Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation
- Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
- Early operable primary breast cancer in elderly (over 70) women: Are they biologically different from their younger counterparts?
- Effects of Resveratrol On Triple Negative (ER-, PR-, HER2-) Breast Cancer Cells
- Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer
- Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study
- Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements
- Epstein-Barr virus and breast cancer: Serological study in a high-incidence area of nasopharyngeal carcinoma
- ER+ PR- breast cancer defines a unique subtype of breast cancer that is driven by growth factor signaling and may be more likely to respond to EGFR targeted therapies
- Estrogen receptor positive operable breast cancer: Does menopausal status impact on HER2 and progesterone receptor status?
- Exploring the use and impact of adjuvant Trastuzumab for HER2-positive breast cancer patients in a large UK cancer network
- Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: Relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2
- Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk
- Fifteen-year trends in metastatic breast cancer survival in Greece
- Flaxseed oil-trastuzumab interaction in breast cancer
- Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474, human breast cancer cells
- Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation
- Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells
- HER 2 ( erb B-2)-targeted effects of the ϖ-3 polyunsaturated. Fatty acid α-linolenic acid (ALA; 18:3n-3) in breast cancer cells: the fat features of the Mediterranean diet as an anti-HER2 cocktail
- HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
- Hormone Receptor Status and Breast Cancer Survival among Hispanic and Non-Hispanic White Women over 10 Years of Follow-Up
- Impact of BMI on clinical outcome of HER2-positive breast cancer
- Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
- Improved Outcomes of Breast-Conserving Therapy for Patients with Ductal Carcinoma in Situ
- Individualized surveillance and follow-up based on breast cancer (BC) subtypes and risk of relapse in BC patients who received curative surgery
- Innate immune profile of inflammatory breast cancer patients
- Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
- Long-term observational follow-up study of breast cancer diagnosed in women ≤40 years old
- Low-density lipoprotein receptor-related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas
- Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
- Mammographic Breast Density and Subsequent Risk of Breast Cancer in Postmenopausal Women According to Tumor Characteristics
- Measles virus antigens in breast cancer
- Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- Microscopic disease after neoadjuvant therapy in inflammatory breast cancer
- Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells
- Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer
- Molecular subtyping of male breast cancer by immunohistochemistry
- mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib
- Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype
- Obesity at Diagnosis Is Associated with Inferior Outcomes in Hormone Receptor Positive Breast Cancer
- Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (HerceptinTM) in breast cancer cells with Her-2/neu oncogene amplification
- Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
- Outcomes of inflammatory versus noninflammatory T4 breast cancers in the age of taxanes and trastuzumab
- Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
- Potential Impact of USPSTF Recommendations on Early Diagnosis of Breast Cancer
- Predictive role of molecular subtypes in response to neoadjuvant chemotherapy in breast cancer patients in northeast china
- Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer
- Prevention of mammary tumorigenesis by aqueous and lipid pomegranate fruit extracts (PFE's): In vitro and in vivo studies
- Prognosis and Outcome of Small (1 cm), Node-Negative Breast Cancer on the Basis of Hormonal and HER-2 Status
- Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
- Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
- Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
- Quercetin-3-methyl ether inhibits lapatinib-sensitive and -resistant breast cancer cell growth by inducing G2/M arrest and apoptosis
- Race and Hormone Receptor-Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial
- Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation
- Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate
- Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer: Results from the GeparQuattro study (GBG 40)
- Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer
- Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation
- Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and HER2 receptor status
- Simultaneous modulation of COX-2, p300, Akt and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells
- Subtypes, race and long-term survival in the Carolina Breast Cancer Study
- tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO)
- The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer
- The Association between Prognostic Demographic and Tumor Characteristics of Breast Carcinomas with Serum 25-OH Vitamin D Levels
- The effect of trastuzumab alone and combined with α-linolenic acid, γ-tocopherol, sesame lignan and its metabolites on the growth of BT-474 and MCF-7 human breast cancer cells
- The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature
- Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
- Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
- Trastuzumab-Resistant HER2-Driven Breast Cancer Cells Are Sensitive to Epigallocatechin-3 Gallate
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
- Tumor infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
- Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study
- Vitamin D Deficiency is Correlated with Poor Outcomes in Patients with Luminal-type Breast Cancer
- Zerumbone Down-regulates Chemokine Receptor CXCR4 Expression Leading to Inhibition of CXCL12-Induced Invasion of Breast and Pancreatic Tumor Cells